Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xavier Padanilam
Observed names:
X Padanilam,
X. Padanilam
Institution:
Department of Health
Observed institutions:
University of the Witwatersrand,
Department of Health
OpenAlex ID:
A5083781913
Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study
2010
·
Keertan Dheda
, Karen Shean
, et al.
·
The Lancet
·
276
PDF
Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study
2014
·
Elize Pietersen
, Elisa Ignatius
, et al.
·
The Lancet
·
275
Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study
2018
·
Kathryn Schnippel
, Norbert Ndjeka
, et al.
·
The Lancet Respiratory Medicine
·
273
Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis
2015
·
N. Ndjeka
, F. Conradie
, et al.
·
The International Journal of Tuberculosis and Lung Disease
·
155
High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen
2018
·
Norbert Ndjeka
, Kathryn Schnippel
, et al.
·
European Respiratory Journal
·
139
PDF
Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: a cross-sectional and longitudinal study
2021
·
Nazir Ahmed Ismail
, Shaheed Vally Omar
, et al.
·
The Lancet Infectious Diseases
·
128
Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa
2013
·
Karen Shean
, Elizabeth Streicher
, et al.
·
PLoS ONE
·
117
PDF
Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort study
2022
·
Norbert Ndjeka
, Jonathon R Campbell
, et al.
·
The Lancet Infectious Diseases
·
104
PDF
Treatment outcomes in multidrug resistant tuberculosis-human immunodeficiency virus Co-infected patients on anti-retroviral therapy at Sizwe Tropical Disease Hospital Johannesburg, South Africa
2015
·
Teye Umanah
, Jabulani Ncayiyana
, et al.
·
BMC Infectious Diseases
·
47
PDF
QTc and anti-tuberculosis drugs: a perfect storm or a tempest in a teacup? Review of evidence and a risk assessment
2018
·
I. Monedero-Recuero
, L. Hernando-Marrupe
, et al.
·
The International Journal of Tuberculosis and Lung Disease
·
37
Implementing novel regimens for drug-resistant TB in South Africa: what can the world learn?
2020
·
N. Ndjeka
, J. Hughes
, et al.
·
The International Journal of Tuberculosis and Lung Disease
·
29
PDF
Factors influencing specialist care referral of multidrug- and extensively drug-resistant tuberculosis patients in Gauteng/South Africa: a descriptive questionnaire-based study
2013
·
Deliwe Nkosi
, Saskia Janssen
, et al.
·
BMC Health Services Research
·
25
PDF
Patient and provider costs of the new BPaL regimen for drug-resistant tuberculosis treatment in South Africa: A cost-effectiveness analysis
2024
·
Denise Evans
, Kamban Hirasen
, et al.
·
PLoS ONE
·
20
Correction: Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa
2013
·
Karen Shean
, Elizabeth Streicher
, et al.
·
PLoS ONE
·
15
PDF
Clinical perspectives on treatment of rifampicin-resistant/multidrug-resistant TB
2020
·
V. Cox
, L. McKenna
, et al.
·
The International Journal of Tuberculosis and Lung Disease
·
14
PDF
Treatment outcomes of pre- and extensively drug-resistant tuberculosis in Johannesburg, South Africa
2018
·
J. Nkurunziza
, A. S. Karstaedt
, et al.
·
The International Journal of Tuberculosis and Lung Disease
·
10
Responding to SARS-CoV-2 in South Africa: what can we learn from drug-resistant tuberculosis?
2020
·
Norbert Ndjeka
, Francesca Conradie
, et al.
·
European Respiratory Journal
·
6
PDF
How Many Sputum Culture Results Do We Need To Monitor Multidrug-Resistant-Tuberculosis (MDR-TB) Patients during Treatment?
2012
·
Saskia Janssen
, Xavier Padanilam
, et al.
·
Journal of Clinical Microbiology
·
6
Anti-Tuberculosis Drugs and Adverse Events
2021
·
Hannah Yejin Kim
, Jin-Gun Cho
, et al.
·
Springer eBooks
·
4
Outcomes of multidrug resistant tuberculosis treatment among human immunodeficiency virus co-infected patients taking anti-retroviral treatment at Sizwe Tropical Disease Hospital Johannesburg, South Africa
2016
·
T. Umanah
, J. Ncayiyana
, et al.
·
International Journal of Infectious Diseases
·
1
PDF
Iqbal Haroon Master
2021
·
N Ndjeka
, A Reuter
, et al.
·
South African Medical Journal
PDF
Early treatment outcomes of patients with extensively drug resistant tuberculosis in South Africa
2014
·
S. Janssen
, C.N. Menezes
, et al.
·
International Journal of Infectious Diseases
PDF
Show more works
View as search
Works count:
23
Citation count:
1,681
H-index:
14
I10-index:
16
Year
Topic
Type